M

Munachimso-Care

BE1009.079.023

About Munachimso-Care

Munachimso-Care is a private limited company (BV/SRL) based in Lennik, founded in 2024. For the 2025 financial year, Munachimso-Care reported a profit of €90,288. Revenue was not published, which is common for abbreviated accounts. The gross margin came to €115,926. Equity stands at €92,288, a solvency ratio of 79%.

Juridical situation
Normal situation
Company number
1009.079.023
Founding date
Founded on 03-05-2024
EUID number
BEKBOBCE.1009.079.023
Type of enterprise
Rechtspersoon
Location
Frans Van Der Steenstraat 71 Lennik 1750
Juridical form
BV — Private limited company (BV/SRL)

Financial ratios

Profit
€ 90K
Equity
€ 92K
Gross margin
€ 116K
Health
Solvability > 25%
79.1%
Liquidity > 1.0
4.74
Profitability > 0%
97.8%
2025
Gross margin
€ 116K
EBITDA
€ 116K
Profit
€ 90K
Equity
€ 92K
Solvability
79.05%
Debt
€ 24K
Cash
€ 97K

Frequently asked questions

Answers to the most common questions about Munachimso-Care, based on official government data and the filed annual accounts.

What is the VAT number of Munachimso-Care?

The VAT number of Munachimso-Care is BE1009.079.023.

When was Munachimso-Care established?

Munachimso-Care was founded in 03-05-2024.

What is the official address of Munachimso-Care?

The official address of Munachimso-Care is Frans Van Der Steenstraat 71 Lennik 1750.

What is the legal form of Munachimso-Care?

The juridical form of Munachimso-Care is Private limited company (BV/SRL).

What is the annual revenue of Munachimso-Care?

The 2025 accounts of Munachimso-Care do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.

Is Munachimso-Care a reliable company?

Munachimso-Care is a registered Rechtspersoon with company number 1009.079.023 and can be verified through the official CBE database.

What is the credit limit of Munachimso-Care?

The estimated credit limit of Munachimso-Care is €127,981.

Is Munachimso-Care still active?

Munachimso-Care currently has the status "Normal situation" and is active.

Further reading

View all insights

Sources